(PDF) Adenocarcinoma of the Lung With EGFR Gene Mutation

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

OncoTargets and Therapy - New Zealand

doi 10.2147/ott.s143501

Full Text

Open PDF

Abstract

Available in full text

Date

September 1, 2017

Authors

Li Xu

Qian Wang

Lin Wu

Publisher

Informa UK Limited

Related search

Squamous Cell Transformation and EGFR T790M Mutation as Acquired Resistance Mechanisms in a Patient With Lung Adenocarcinoma Treated With a Tyrosine Kinase Inhibitor: A Case Report

English

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal

2020

English

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Japanese Journal of Lung Cancer

English

Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report From Iran

2018

English

Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Molecular Cancer Therapeutics

Cancer Research

Oncology

2016

English

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Journal of Thoracic Oncology

English

Responses to Crizotinib and Chemotherapy in Patients With Lung Adenocarcinoma Harboring a Concomitant EGFR Mutation and ALK Gene Rearrangement: A Case Report and Review of the Literature

Molecular and Clinical Oncology

Cancer Research

Oncology

2017

English

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

English

Amanote Research

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

OncoTargets and Therapy - New Zealand

doi 10.2147/ott.s143501

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Squamous Cell Transformation and EGFR T790M Mutation as Acquired Resistance Mechanisms in a Patient With Lung Adenocarcinoma Treated With a Tyrosine Kinase Inhibitor: A Case Report

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report From Iran

Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Responses to Crizotinib and Chemotherapy in Patients With Lung Adenocarcinoma Harboring a Concomitant EGFR Mutation and ALK Gene Rearrangement: A Case Report and Review of the Literature

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma